Pharma Mar (PHM:NYSE) Annual Reports & Investor Relations Material

Overview

PulteGroup, Inc. is a leading player in the American homebuilding industry. The company, which primarily operates through its subsidiaries, focuses on acquiring and developing land for residential purposes and constructing quality homes. PulteGroup offers a variety of home designs, ranging from single-family detached houses to townhomes, condominiums, and duplexes. The brand operates through various subdivisions, including Centex, Pulte Homes, Del Webb, DiVosta Homes, American West, and John Wieland Homes and Neighborhoods. As of December 31, 2022, PulteGroup controlled over 211,000 lots, out of which it owned approximately 109,000, while the remainder were under land option agreements. Besides homebuilding, the company is also involved in financing activities, including mortgage loan origination primarily for homebuyers. Further, PulteGroup sells servicing rights for the loans it originates and provides title insurance policies, examination, and closing services to homebuyers. The company was formed in 1950 and has its headquarters in Atlanta, Georgia. PulteGroup's presence in the American real estate market is widespread and impactful, positioning the company as a formidable player in the industry.

Frequently Asked Questions

What is Pharma Mar's ticker?

Pharma Mar's ticker is PHM

What exchange is Pharma Mar traded on?

The company's shares trade on the NYSE stock exchange

Where are Pharma Mar's headquarters?

They are based in Atlanta, Georgia

How many employees does Pharma Mar have?

There are 1001-5000 employees working at Pharma Mar

What is Pharma Mar's website?

It is pharmamar.com/en

What type of sector is Pharma Mar?

Pharma Mar is in the Industrial Goods sector

What type of industry is Pharma Mar?

Pharma Mar is in the Residential Construction industry

Who are Pharma Mar's peers and competitors?

The following five companies are Pharma Mar's industry peers:

- Toll Brothers

- Watkin Jones

- M/I Homes

- Bellway

- The Marcus